ACADEMIC QUALIFICATION
-
MSurg(UM)(2012), (Surgeri)
Universiti Malaya (UM)
-
MBChB(2006), (Perubatan dan Pembedahan)
University of Leicester, Leicester, Uk
-
Expert Training, (Farmasi Klinikal)
University of Leicester, Leicester, Uk
ADMINISTRATIVE DUTIES
MEMBERSHIPS
PHASE 1 CO-ORDINATOR , COMMITTEE MEMBER
2021 to 2023 (University)
DEPUTY CHAIRMAN, VICE PRESIDENT
2021 to 2022 (National)
SCIENTIFIC CHAIRMAN ENDOUROLOGY IN THE COVID ERA, COMMITTEE MEMBER
2021 to 2021 (International)
CO-SCIENTIFIC CHAIRMAN 30TH MALAYSIAN UROLOGICAL CONFERENCE (VIRTUAL), COMMITTEE MEMBER
2021 to 2021 (International)
PUBLICATIONS
Yii RSL et al., Predictive factors of prostate cancer diagnosis with PSA 4.0e10.0 ng/ml in a multi-ethnic Asian population, Malaysia, Asian Journal of Surgery, https://doi.org/10.1016/j.asjsur.2019.02.014
NY Yap, R Rajandram, KL Ng, J Pailoor, A Fadzli, GC Gobe. Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms. Biomed Research International 2015 (2015), Article ID 476508, 22 pages.
RESEARCH PROJECT
2019 - 2024, Merck Sharp & Dohme (M) Sdn. Bhd
KEYNOTE-676 : Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Bacillus Calmette-Guerin (BCG) in Participants with High-risk Non-muscle Invasive Bladder Cancer (HR NMIBC) that is Persistent or Recurrent Following BCG Induction (KEYNOTE-676) ( Consultant)
2015 - 2020, International Funding
A multi-centre, prospective, longitudinal registry of patients with prostate cancer in Asia ( Consultant)
2016 - 2019, International Funding
A Phase I V Interventional Safety, Efficacy and Quality of Life Study of ELIGARD in Prostate Cancer Patients in Asia (ELIGANT) ( Consultant)
2018 - 2018, International Funding
Robotic-a ssisted percutaneous access Interventional, non-randomized, open-label, non-comparative and First-in-Man Study ( Consultant)
2008 - 2008, Sanofi-Aventis
SAVE-ONCO: A multinational, randomized, double-
blind, placebo-controlled study to evaluate the
efficacy and safety of AVE5026 in the prevention
of venous throboembolism (VTE) in cancer patients
at high risk for VTE and who are undergoing
chemotherapy ( Coordinator)
PAPER PRESENTED
Nocturia, Malaysian Enterostomal Therapy Nursing Education Programme, M&T Network Consultancy Services Sdn Bid (National) (06 Sep 2021 - 27 Nov 2021)
metastatic RCC to contralateral ureter, Malaysian Urological COnference, MUA (National) (24 Nov 2016 - 27 Nov 2016)
Efficacy of Oral Chondroitin Sulphate (urosulf) in Reducing Ureteric Stent Related Symptoms, 14th Urological Association of Asia Congress 2016, UAA & SUA (International) (20 Jul 2016 - 24 Jul 2016)
Percutaneous Nephrolithotomy (PCNL) in a case of Horseshoe Kidney, 27th World Congress on Videourology & Clinical Urology, Thai Urological Association (International) (09 Jun 2016 - 12 Jun 2016)
Ultra-Mini Percutaneous Nephrolithotripsy: A UMMC Experience, Malaysian Urology Conference, MUC (National) (20 Nov 2015 - 22 Nov 2015)
Transrectal Ultrasound Guided Prostate Biopsy Complications - a UMMC experience, 23rd Malaysian Urological Conference, Malaysian Urological Association (National) (21 Nov 2014 - 23 Nov 2014)
Tubulocystic renal cell carcinoma presenting as spontaneous subcapsular haematoma, 22nd Malaysian Urological Conference, Malaysian Urological Association (National) (22 Nov 2013 - 24 Nov 2013)
hair in urethra post scrotal skin hypospadias repair, Malaysian urological conference, MUA (National) (24 Dec 2017 - 26 Dec 2017)
ACADEMIC/PROFESSIONAL SERVICES
(2021) Board Examination for Malaysian Urological Trainees, National, (Internal Examiner)
SOCIAL RESPONSIBILITY ACTIVITIES
